Interestingly, we also observed that CRP, a well‐known inflammatory biomarker, was also elevated in HCA patients, and the AUC of CRP to distinguish HCA patients from non‐HCA patients was 0.5730, indicating that CRP is a not a sensitive biomarker to distinguish HCA patients from non‐HCA patients. The gene discussed is CRP; the disease is hepatocellular adenoma.